|
1
|
Lam DW and LeRoith D: The worldwide
diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. 19:93–96.
2012. View Article : Google Scholar
|
|
2
|
Scheen AJ and Lefèbvre PJ: Insulin action
in man. Diabetes Metab. 22:105–110. 1996.
|
|
3
|
Talchai C, Xuan S, Lin HV, Sussel L and
Accili D: Pancreatic β cell dedifferentiation as a mechanism of
diabetic β cell failure. Cell. 150:1223–1234. 2012.
|
|
4
|
Teodoro JS, Gomes AP, Varela AT, Duarte
FV, Rolo AP and Palmeira CM: Uncovering the beginning of diabetes:
the cellular redox status and oxidative stress as starting players
in hyperglycemic damage. Mol Cell Biochem. 376:103–110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kabelitz D, Geissler EK, Soria B,
Schroeder IS, Fändrich F and Chatenoud L: Toward cell-based therapy
of type I diabetes. Trends Immunol. 29:68–74. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bonner-Weir S and Weir GC: New sources of
pancreatic beta-cells. Nat Biotechnol. 23:857–861. 2005.
|
|
7
|
Michael MD, Kulkarni RN, Postic C, et al:
Loss of insulin signaling in hepatocytes leads to severe insulin
resistance and progressive hepatic dysfunction. Mol Cell. 6:87–97.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El Ouaamari A, Kawamori D, Dirice E, et
al: Liver-derived systemic factors drive β cell hyperplasia in
insulin-resistant states. Cell Rep. 3:401–410. 2013.PubMed/NCBI
|
|
9
|
Tang T, Li L, Tang J, et al: A mouse
knockout library for secreted and transmembrane proteins. Nat
Biotechnol. 28:749–755. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teslovich TM, Musunuru K, Smith AV, et al:
Biological, clinical and population relevance of 95 loci for blood
lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yi P, Park JS and Melton DA: Betatrophin:
a hormone that controls pancreatic β cell proliferation. Cell.
153:747–758. 2013.
|
|
12
|
Fu Z, Yao F, Abou-Samra AB and Zhang R:
Lipasin, thermoregulated in brown fat, is a novel but atypical
member of the angiopoietin-like protein family. Biochem Biophys Res
Commun. 430:1126–1131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang R: Lipasin, a novel
nutritionally-regulated liver-enriched factor that regulates serum
triglyceride levels. Biochem Biophys Res Commun. 424:786–792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quagliarini F, Wang Y, Kozlitina J, et al:
Atypical angiopoietin-like protein that regulates ANGPTL3. Proc
Natl Acad Sci USA. 109:19751–19756. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren G, Kim JY and Smas CM: Identification
of RIFL, a novel adipocyte-enriched insulin target gene with a role
in lipid metabolism. Am J Physiol Endocrinol Metab. 303:E334–E351.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mattijssen F and Kersten S: Regulation of
triglyceride metabolism by Angiopoietin-like proteins. Biochim
Biophys Acta. 1821.782–789. 2012.PubMed/NCBI
|
|
17
|
Oike Y and Tabata M: Angiopoietin-like
proteins - potential therapeutic targets for metabolic syndrome and
cardiovascular disease. Circ J. 73:2192–2197. 2009.PubMed/NCBI
|
|
18
|
Li C: Genetics and regulation of
angiopoietin-like proteins 3 and 4. Curr Opin Lipidol. 17:152–156.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miida T and Hirayama S: Impacts of
angiopoietin-like proteins on lipoprotein metabolism and
cardiovascular events. Curr Opin Lipidol. 21:70–75. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Musunuru K, Pirruccello JP, Do R, et al:
Exome sequencing, ANGPTL3 mutations and familial combined
hypolipidemia. N Engl J Med. 363:2220–2227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Romeo S, Yin W, Kozlitina J, et al: Rare
loss-of-function mutations in ANGPTL family members contribute to
plasma triglyceride levels in humans. J Clin Invest. 119:70–79.
2009.PubMed/NCBI
|
|
22
|
Koishi R, Ando Y, Ono M, et al: Angptl3
regulates lipid metabolism in mice. Nat Genet. 30:151–157. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Romeo S, Pennacchio LA, Fu Y, et al:
Population-based resequencing of ANGPTL4 uncovers variations that
reduce triglycerides and increase HDL. Nat Genet. 39:513–516. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Inukai K, Nakashima Y, Watanabe M, et al:
ANGPTL3 is increased in both insulin-deficient and -resistant
diabetic states. Biochem Biophys Res Commun. 317:1075–1079. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoon JC, Chickering TW, Rosen ED, et al:
Peroxisome proliferator-activated receptor gamma target gene
encoding a novel angiopoietin-related protein associated with
adipose differentiation. Mol Cell Biol. 20:5343–5349. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Quagliarini F, Gusarova V, et al:
Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride
metabolism without impaired glucose homeostasis. Proc Natl Acad Sci
USA. 110:16109–16114. 2013. View Article : Google Scholar
|
|
27
|
Flier SN, Kulkarni RN and Kahn CR:
Evidence for a circulating islet cell growth factor in
insulin-resistant states. Proc Natl Acad Sci USA. 98:7475–7480.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kulkarni RN, Mizrachi EB, Ocana AG and
Stewart AF: Human β-cell proliferation and intracellular signaling:
driving in the dark without a road map. Diabetes. 61:2205–2213.
2012.
|
|
29
|
Kinsey-Jones JS and Murphy KG: Current
models and strategies in the development of antiobesity drugs. Ann
NY Acad Sci. 1245:3–6. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aydin S, Kuloglu T, Aydin S, et al:
Expression of adropin in rat brain, cerebellum, kidneys, heart,
liver and pancreas in streptozotocin-induced diabetes. Mol Cell
Biochem. 380:73–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Imai J, Katagiri H, Yamada T, et al:
Regulation of pancreatic β cell mass by neuronal signals from the
liver. Science. 322:1250–1254. 2008.
|
|
32
|
Jiao Y, Le Lay J, Yu M, Naji A and
Kaestner KH: Elevated mouse hepatic betatrophin expression does not
increase human β-cell replication in the transplant setting.
Diabetes. 63:1283–1288. 2014.PubMed/NCBI
|
|
33
|
Espes D, Lau J and Carlsson PO: Increased
circulating levels of betatrophin in individuals with long-standing
type 1 diabetes. Diabetologia. 57:50–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raghow R: Betatrophin: a liver-derived
hormone for the pancreatic β-cell proliferation. World J Diabetes.
4:234–237. 2013.PubMed/NCBI
|
|
35
|
Zhang R and Abou-Samra AB: Emerging roles
of lipasin as a critical lipid regulator. Biochem Biophys Res
Commun. 432:401–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Smukler SR, Arntfield ME, Razavi R, et al:
The adult mouse and human pancreas contain rare multipotent stem
cells that express insulin. Cell Stem Cell. 8:281–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kushner JA: The role of aging upon β cell
turnover. J Clin Invest. 123:990–995. 2013.
|
|
38
|
Boström P, Wu J, Jedrychowski MP, et al: A
PGC1-α-dependent myokine that drives brown-fat-like development of
white fat and thermogenesis. Nature. 481:463–468. 2012.
|
|
39
|
Novelle MG, Contreras C, Romero-Picó A,
López M and Diéguez C: Irisin, two years later. Int J Endocrinol.
2013:7462812013.PubMed/NCBI
|
|
40
|
Zhang Y, Li R, Meng Y, et al: Irisin
stimulates browning of white adipocytes through mitogen-activated
protein kinase p38 MAP kinase and ERK MAP kinase signaling.
Diabetes. 63:514–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sanchis-Gomar F and Perez-Quilis C: The
p38-PGC-1α-irisin-betatrophin axis: exploring new pathways in
insulin resistance. Adipocyte. 3:67–68. 2014.
|
